| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/20/2008 | EP1890150A1 Determination of agonistic autoantibodies associated with humoral kidney rejection |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889908A1 Anti-cd14 antibody-fused protein |
| 02/20/2008 | EP1889851A1 PAX2 and PAX8 as targets for immunologic and molecular tumour treatment strategies |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889631A1 Cell growth inhibition |
| 02/20/2008 | EP1889630A1 Vaccines |
| 02/20/2008 | EP1889626A1 Hip kinase for fertility control |
| 02/20/2008 | EP1889062A2 Specific binding sites in collagen for integrins and use thereof |
| 02/20/2008 | EP1889058A1 Diagnosis and treatment of endometriosis |
| 02/20/2008 | EP1888752A2 Hepatitis c virus vaccine |
| 02/20/2008 | EP1888751A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/20/2008 | EP1888648A2 Methods of treating, diagnosing or detecting cancer |
| 02/20/2008 | EP1888646A2 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 02/20/2008 | EP1888645A2 Anti-cd16 binding molecules |
| 02/20/2008 | EP1888644A1 Anti-il2 antibodies |
| 02/20/2008 | EP1888638A2 Method of producing antibodies with modified fucosylation level |
| 02/20/2008 | EP1888636A2 Method for the purification of antibodies |
| 02/20/2008 | EP1888634A2 Mhc class i and ii peptide antigens derived from tumour antigen 5t4 |
| 02/20/2008 | EP1888632A2 Cytokine |
| 02/20/2008 | EP1888631A2 Therapeutic composition for use in the prevention and treatment of bone metastases |
| 02/20/2008 | EP1888625A2 Malaria vaccines |
| 02/20/2008 | EP1888622A1 Compositions for inducing an immune response against hepatitis b |
| 02/20/2008 | EP1888621A2 Porcine circovirus type 2 vaccines |
| 02/20/2008 | EP1888114A2 Anti- mcp-1 antibodies, compositions, methods and uses |
| 02/20/2008 | EP1888113A2 Tweak binding antibodies |
| 02/20/2008 | EP1888112A2 Psk-1 and its modulators for the treatment/diagnosis of cancer |
| 02/20/2008 | EP1888111A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 02/20/2008 | EP1888110A2 Non-injection immunotherapy |
| 02/20/2008 | EP1888109A2 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 02/20/2008 | EP1888108A2 Silicibacter sp. strain useful for genetic transformation of marine algae and production of antibiotic agents |
| 02/20/2008 | EP1888107A2 Novel vaccine formulations |
| 02/20/2008 | EP1888105A2 P53 vaccines for the treatment of cancers |
| 02/20/2008 | EP1492891B1 Methods of virus production |
| 02/20/2008 | EP1326638B9 Vaccines against cancers |
| 02/20/2008 | EP1289548B1 Immune system stimulating means |
| 02/20/2008 | EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus |
| 02/20/2008 | EP1218028B1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigenspecific t cell responses |
| 02/20/2008 | EP1154791B1 Neisserial vaccine compositions and methods |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | EP1100922B1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/20/2008 | EP1099759B1 Vibrio cholerae vaccine candidates and methods of their constructing |
| 02/20/2008 | EP1072272B1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 02/20/2008 | EP0970966B1 Fungal antigens and process for producing the same |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0907746B1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/20/2008 | EP0837687B1 Hapten modified tumor cell extract and methods of treating cancer |
| 02/20/2008 | EP0768890B1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128598A Methods of producing influenza vaccine compositions |
| 02/20/2008 | CN101128597A Use of an agent produced from a parasite for prevention and control of diseases |
| 02/20/2008 | CN101128485A Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4) |
| 02/20/2008 | CN101128484A Compositions and methods relating to anti IGF-1 receptor antibodies |
| 02/20/2008 | CN101128478A N protein mutants of porcine reproductive and respiratory syndrome virus |
| 02/20/2008 | CN101128217A Use of a modified proxvirus for the rapid induction of immunity against a poxvirus or other infectious agents |
| 02/20/2008 | CN101128216A Delivery vehicles, bioactive substances and viral vaccines |
| 02/20/2008 | CN101128215A Immunogenic composition for use in vaccination against staphylococcei |
| 02/20/2008 | CN101128207A Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 02/20/2008 | CN101128182A Heavy chain and domain antibodies |
| 02/20/2008 | CN101126095A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126094A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101125890A Monoclonal antibody for resisting bovine prion protein and application thereof |
| 02/20/2008 | CN101125888A Expression production for recombination immunoglobulin capable of specifically identifying blood vessel endothelial cell growth factor and application thereof |
| 02/20/2008 | CN101125202A Protein vaccine used for processing immune tolerant treatment to hepatitis B |
| 02/20/2008 | CN100369934C Monoclonal antibody against human 4-1BBL and its use |
| 02/20/2008 | CN100369933C Preparation and use of monoclonal antibody against human GL50 |
| 02/20/2008 | CN100369931C Monoclonal antibody against human B7-1 molecule and its use |
| 02/20/2008 | CN100369930C Chimeric and humanized antibodies to alpha5beta1 integrin that modulate angiogenesis |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | USRE40070 Antibody purification |
| 02/19/2008 | US7332595 DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 02/19/2008 | US7332588 Genome of the HIV-1 inter-subtype (C/B) and use thereof |
| 02/19/2008 | US7332585 Bispecific single chain Fv antibody molecules and methods of use thereof |
| 02/19/2008 | US7332582 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332572 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 02/19/2008 | US7332523 TNP-470 polymer conjugates and use thereof |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/19/2008 | US7332354 bioconjugation; luciferins; biopolymer labels |
| 02/19/2008 | US7332340 Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 02/19/2008 | US7332321 Fabricating wet spun or electrospun fibers using nanometer scale liquid crystalline viral particle suspensions where particle composition and function can be modified genetically to include binding or nucleating conjugate moieties while maintaining fibrous structure end product |
| 02/19/2008 | US7332298 Nucleic acids encoding multimeric proteins of TNF superfamily ligands |
| 02/19/2008 | US7332293 Neutral amino acid transporter binding method |
| 02/19/2008 | US7332269 Hepatitis C virus (HCV) diagnosis kits wherein ability of proteins to bind anti-HCV murine antibodies has been removed; solid phase synthesis |
| 02/19/2008 | US7332174 Mutant forms of cholera holotoxin as an adjuvant |
| 02/19/2008 | US7332173 Group A streptococcal polysaccharide immunogenic compositions and methods |
| 02/19/2008 | US7332172 antigens that stimulate protective antibodies against enterotoxigenic Escherichia coli; proteins encoded by cssA and cssB genes |
| 02/19/2008 | US7332171 DNA sequences, vectors, host cells; proteins may be involved in immune avoidance |
| 02/19/2008 | US7332170 Classical swine fever virus virulence determinant and a novel classical swine fever vaccine |
| 02/19/2008 | US7332169 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine |
| 02/19/2008 | US7332168 Composition for the elimination of autoreactive B-cells |
| 02/19/2008 | US7332167 Diagnosis of chronic infections by Candida albicans |
| 02/19/2008 | US7332166 Glycosylated specificity exchangers |
| 02/19/2008 | US7332165 Antibody production in farm animals |
| 02/19/2008 | US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/19/2008 | US7332162 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 02/19/2008 | US7332161 Treatment of disease with antibodies against high molecular weight kininogen domain 5 |
| 02/19/2008 | US7332157 Methods for human allografting |